Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-09 09:07 am Purchase | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | Empery Asset Management, LP | 4,000,000 6.700% | 4,000,000 (New Position) | Filing History |
| 2024-01-09 09:06 am Purchase | 2023-12-31 | 13G | Cyngn Inc. CYN | Empery Asset Management, LP | 354 9.990% | 354 (New Position) | Filing History |
| 2024-01-09 09:05 am Purchase | 2023-12-31 | 13G | SOBR Safe, Inc. SOBR | Empery Asset Management, LP | 1,092 6.090% | 1,092 (New Position) | Filing History |
| 2024-01-09 09:03 am Purchase | 2023-12-31 | 13G | Nuvve Holding Corp. NVVE | Empery Asset Management, LP | 11,260 9.990% | 11,260 (New Position) | Filing History |
| 2024-01-08 10:26 am Sale | 2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Empery Asset Management, LP | 151,654 2.650% | -54,969 (-26.60%) | Filing History |
| 2024-01-08 10:25 am Unchanged | 2023-12-31 | 13G | Kiromic BioPharma, Inc. KRBP | Empery Asset Management, LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-01-08 10:23 am Purchase | 2023-12-31 | 13G | RedHill Biopharma Ltd. RDHL | Empery Asset Management, LP | 414,607 3.190% | 414,607 (New Position) | Filing History |
| 2024-01-08 10:22 am Purchase | 2023-12-31 | 13G | Permex Petroleum Corporation OILCF | Empery Asset Management, LP | 52,083 4.990% | 52,083 (New Position) | Filing History |
| 2023-01-13 08:04 am Purchase | 2022-12-31 | 13G | RedHill Biopharma Ltd. RDHL | Empery Asset Management, LP | 6,200 6.120% | 6,200 (New Position) | Filing History |
| 2023-01-13 08:02 am Purchase | 2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Empery Asset Management, LP | 206,623 5.120% | 206,623 (New Position) | Filing History |
| 2023-01-13 08:00 am Purchase | 2022-12-31 | 13G | Volcon, Inc. VLCN | Empery Asset Management, LP | 8 9.990% | 8 (New Position) | Filing History |
| 2023-01-12 10:03 am Purchase | 2022-12-31 | 13G | Permex Petroleum Corporation OILCF | Empery Asset Management, LP | 13,021 9.580% | 13,021 (New Position) | Filing History |
| 2023-01-12 10:02 am Purchase | 2022-12-31 | 13G | Kiromic BioPharma, Inc. KRBP | Empery Asset Management, LP | 163,268 9.990% | 163,268 (New Position) | Filing History |
| 2023-01-12 10:01 am Unchanged | 2022-12-31 | 13G | Direct Digital Holdings, Inc. DRCT | Empery Asset Management, LP | 270,000 4.990% | 0 (Unchanged) | Filing History |
| 2023-01-12 10:01 am Sale | 2022-12-31 | 13G | iSpecimen Inc. ISPC | Empery Asset Management, LP | 21,875 4.680% | -1,442 (-6.18%) | Filing History |
| 2022-03-18 5:15 pm Purchase | 2022-02-10 | 13G | Direct Digital Holdings, Inc. DRCT | Empery Asset Management, LP | 270,000 9.640% | 270,000 (New Position) | Filing History |
| 2022-01-24 10:35 am Sale | 2021-12-31 | 13G | Titan Pharmaceuticals, Inc. TTNP | Empery Asset Management, LP | 43,022 4.990% | -4,206 (-8.91%) | Filing History |
| 2022-01-24 10:33 am Purchase | 2021-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Empery Asset Management, LP | 1,484 4.050% | 1,484 (New Position) | Filing History |
| 2022-01-24 10:32 am Purchase | 2021-12-31 | 13G | iSpecimen Inc. ISPC | Empery Asset Management, LP | 23,317 5.340% | 23,317 (New Position) | Filing History |
| 2022-01-24 10:30 am Purchase | 2021-12-31 | 13G | Polished.com Inc. POL | Empery Asset Management, LP | 3,380 4.990% | 713 (+26.74%) | Filing History |